Apellis Pharmaceuticals, Inc. (APLS)

19.94 -0.59 (-2.87%) USD  |  NASDAQ  |  Jan 16, 16:00
20.05 +0.11 (+0.55%) Pre-Market: 20:00
More

Apellis Pharmaceuticals EV to Revenues

EV to Revenues Chart

View EV to Revenues for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade